Tag Archives: triple-negative breast cancer

Generic Name: succinylcholine Brand and Other Names: Anectine, suxamethonium, Quelicin Drug Class: Neuromuscular Blockers, Depolarizing What is succinylcholine, and what is it used for? Succinylcholine is a skeletal muscle relaxant used while performing medical procedures under general anesthesia, including tracheal intubation, mechanical ventilation, and surgeries. Succinylcholine belongs to a class of medication known as depolarizing neuromuscular …

Generic Name: vancomycin Brand Names: Vancocin, Firvanq Drug Class: Glycopeptides What is vancomycin, and what is it used for? Vancomycin is an antibiotic typically used to treat colon inflammation (colitis) and diarrhea that may occur sometimes after antibacterial treatment, and bacterial infections that are resistant to other antibiotics. Vancomycin belongs to a class of antibiotics known as glycopeptides which are …

Kabuki syndrome is caused by a mutation in the KMT2D gene or the KDM6A gene, whereas, in some cases, the cause remains unknown. Most cases (between 55 and 80 percent) of Kabuki syndrome are caused by mutations in the KMT2D gene that is inherited in an autosomal dominant pattern. This means a mutation in only one copy of the KMT2D gene in …

Substance-induced psychosis is initially treated by cessation of the substance causing psychosis and the following treatment plans. The initial treatment for substance-induced psychosis is the cessation of the substance that causes psychosis and monitoring the person in a safe and calm environment. Some of the drugs commonly prescribed for the treatment of substance-induced psychosis include: Antianxiety drugs, such as benzodiazepines, …

About 10 to 70 percent of people with schizophrenia do recreational drugs. About 10 to 70 percent of people with schizophrenia do recreational drugs. According to a study, 11.9 percent of people with schizophrenia had drug abuse.  One in four people with schizophrenia had a cannabis use disorder. According to the American Addiction Center, 50 percent of people with schizophrenia …

Tardive dyskinesia symptoms can make it difficult to carry out daily physical tasks, lowering one's quality of life. Tardive dyskinesia is caused as a side effect of neuroleptic drugs and brings about involuntary and uncontrolled movements, which include grimacing, twitching, and thrusting. It is a neurological syndrome marked by random movements that usually occur in the jaws, tongue, face, or …

Risks to childbearing later in life include potential miscarriage, chromosome abnormalities, and gestational diabetes. Learn more about pregnancy after age 35 Nowadays, having a baby after 35 is becoming more and more common. While conceiving and delivering a healthy baby despite advanced maternal age is possible, there are risks to childbearing later in life—including potential miscarrage, chromosome abnormalities, and gestational diabetes. …

Learn the differences between dissociative identity disorder and schizophrenia, including their different causes, treatments, signs and symptoms, and diagnosis. Schizophrenia and dissociative identity disorder may have some overlapping symptoms. Hence, it may often be tricky to clinically differentiate between the two diseases. In both of these conditions, affected people develop a sense of fragmented reality. Between 9 and 50 percent …

Effective treatment of schizophrenia, such as the negative symptoms, includes a combination of drugs, behavior therapy, and support therapy. There are three types of symptoms in schizophrenia—positive, negative, and cognitive.  Although it is easier to recognize positive symptoms and cognitive symptoms, treating negative symptoms is a challenging task because these symptoms, such as lack of motivation, make it harder for …

There is no effective treatment available to enhance cognitive function in patients with schizophrenia. Problems in cognitive function occur early in people affected with schizophrenia. Cognitive impairment is a frequent symptom occurring in nonelderly patients with schizophrenia or other brain disorders that involve degenerative changes. Treating cognitive symptoms through cognitive enhancement remains a clinically unresolved issue. To date, there is …